SCHEMBL26337448

SCHEMBL26337448

c1ccc(-c2c(-c3ccccc3)c3cc(-c4cccc(N(c5cccc(-c6ccc7ccccc7c6)c5)c5ccc6c(ccc7ccccc76)c5)c4)ccc3c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.39
HSD17B2 P37059 4/20 0.39
CYP1A2 P05177 4/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2B6 P20813 2/20 0.39
CYP2C19 P33261 2/20 0.39
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
HPRT1 P00492 1/20 0.35
GPR84 Q9NQS5 2/20 0.34
CYP1B1 Q16678 3/20 0.33
CYP1A1 P04798 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
SOS1 Q07889 1/20 0.33
CYP17A1 P05093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26339914 0.98 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337567 0.98 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337487 0.98 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337499 0.98 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337395 0.97 ESR1 (0.40) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26335839 0.97 HSD17B1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337483 0.96 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337490 0.96 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26339956 0.96 ESR1 (0.39) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6
SCHEMBL26337456 0.96 HSD17B1 (0.40) HSD17B1HSD17B2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 HSD17B1 2697/4885HSD17B2 2994/4885CYP1A2 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.